FDA-cleared profile

Vivid E80/ Vivid E90/ Vivid E95

GE Medical Systems Ultrasound and

The Vivid E80, E90, and E95 provide cardiovascular and general diagnostic ultrasound; this release adds AI-assisted cardiac measurements and Doppler recognition plus expanded ventricular, atrial, tricuspid, and application-launch functions.

Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.

Clinical fit

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
The Vivid E80, E90, and E95 provide cardiovascular and general diagnostic ultrasound; this release adds AI-assisted cardiac measurements and Doppler recognition plus expanded ventricular, atrial, tricuspid, and application-launch functions.
FDA source Exact FDA submission Checked 2026-09-03
Intended users
Qualified and trained physicians, cardiac sonographers, and ultrasound professionals.
FDA source Exact FDA submission Checked 2026-09-03
Care setting and population
Echo labs, hospitals, operating rooms, catheterization and electrophysiology labs, and private medical offices.
FDA source Exact FDA submission Checked 2026-09-03
Workflow role
Cardiovascular ultrasound acquisition, quantification, reporting, and AI-assisted measurement across 2D, Doppler, and 3D/4D workflows.
Public source Exact FDA submission Checked 2026-09-03
Required input
Live ultrasound data from supported probes plus qualified third-party DICOM images for selected AFI and Auto EF functions.
FDA source Exact FDA submission Checked 2026-09-03
Output and human action
Cardiac and general ultrasound images, measurements, strain and ejection-fraction analyses, Doppler measurements, and DICOM reports.
FDA source Exact FDA submission Checked 2026-09-03
Limitations
K200743 did not require clinical studies. AI Auto Measure and related tools automate defined measurements but do not replace acquisition quality review or clinical interpretation; later Vivid releases must not be attributed to this clearance.
FDA source Exact FDA submission Checked 2026-09-03

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K200743
FDA source Exact FDA submission Checked 2026-08-31
Modality
Ultrasound
FDA source Exact FDA submission Checked 2026-09-03
Anatomy
Heart/Cardiovascular
FDA source Exact FDA submission Checked 2026-09-03
Clearance type
510(k)
FDA source Exact FDA submission Checked 2026-08-31
Decision date
2020-07-23
FDA source Exact FDA submission Checked 2026-08-31
FDA status
FDA-cleared
FDA source Exact FDA submission Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
LAN or wireless DICOM workflow with storage, reporting, PDF read, and a launchpad restricted to qualified compatible applications; validate probe, archive, third-party DICOM, measurement, and report interoperability.
Public source Exact FDA submission Checked 2026-09-03
Deployment and data flow
Mobile cardiovascular ultrasound console with supported transducers, software options, network access, and optional storage or printing devices.
Public source Exact FDA submission Checked 2026-09-03
Security and privacy
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-03

Public materials reviewed for this batch do not establish the complete security posture for the exact release. Request data-flow, identity, audit, encryption, retention, support-access, vulnerability-management, backup, and incident-response evidence.

Training and support
Only qualified and trained physicians, cardiac sonographers, and ultrasound professionals. should operate or interpret the system. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
FDA source Exact FDA submission Checked 2026-09-03
Monitoring and change control
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: K200743 did not require clinical studies. AI Auto Measure and related tools automate defined measurements but do not replace acquisition quality review or clinical interpretation; later Vivid releases must not be attributed to this clearance.
Public source Exact FDA submission Checked 2026-09-03

Release and scope verification

Map the installed model, build, options, population, anatomy, inputs, and outputs to K200743 before acceptance.

exact submission · checked 2026-09-03

Later product-family features are not evidence that this cleared release includes them.

Interoperability acceptance

LAN or wireless DICOM workflow with storage, reporting, PDF read, and a launchpad restricted to qualified compatible applications; validate probe, archive, third-party DICOM, measurement, and report interoperability.

exact submission · checked 2026-09-03

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. K200743 did not require clinical studies. AI Auto Measure and related tools automate defined measurements but do not replace acquisition quality review or clinical interpretation; later Vivid releases must not be attributed to this clearance.

exact submission · checked 2026-09-03

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-03

Vendor productivity claims are scenario inputs, not guaranteed local savings.

Lifecycle monitoring

Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: K200743 did not require clinical studies. AI Auto Measure and related tools automate defined measurements but do not replace acquisition quality review or clinical interpretation; later Vivid releases must not be attributed to this clearance.

exact submission · checked 2026-09-03

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.

Evidence summary
K200743 reports system verification and validation but no clinical study. The release-specific AI Auto Measure 2D workflow reduced required user interactions from 19 to four, described as a 79% reduction; outcome or diagnostic benefit was not established.
Public source Exact FDA submission Checked 2026-09-03
Reported sensitivity
Not applicable
Not applicable Not applicable Checked 2026-09-03

Sensitivity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.

Reported specificity
Not applicable
Not applicable Not applicable Checked 2026-09-03

Specificity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.

AI Auto Measure interaction reduction

79 %

User interactions reduced from 19 to 4 in Vivid E80/ Vivid E90/ Vivid E95.

Tested version: Vivid E80/E90/E95 release cleared in K200743

K200743 FDA performance package for Vivid E80/ Vivid E90/ Vivid E95

Manufacturer nonclinical ultrasound-system, software, measurement, DICOM, and safety verification · Representative cardiovascular and general diagnostic ultrasound applications

exact submission · Tested version: Vivid E80/E90/E95 release cleared in K200743 · Sponsor or vendor study

K200743

Manufacturer evidence submitted for substantial equivalence; local clinical, technical, and workflow acceptance remains necessary.

Economics and lifecycle

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-03

No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

Reimbursement and coding
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the device within the applicable imaging or surgical service line and verify payer, site-of-service, and coding assumptions independently.
Public source Not applicable Checked 2026-09-03

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

Build a local total-cost and value model; do not infer reimbursement from FDA clearance.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K200743 by exact submission identifier.
Public source Exact FDA submission Checked 2026-09-03

A zero-result exact-identifier search does not prove that no recall, correction, adverse-event report, or product-family safety signal exists.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
24Fields reviewed
8Source classes checked
20Unreviewed PubMed leads
10Unreviewed trial leads
0Unreviewed FDA recall leads

Recovered from the prior exact-submission extraction and normalized under the current provenance rules. Exact FDA materials, current product-family sources, selected clinical literature, reimbursement context, and exact-identifier recall candidates were reviewed. Pricing, contracted services, enabled options, final security architecture, and local interoperability remain organization-specific evidence. Automated exact-name discovery found 20 PubMed and 10 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads remain unpublished until a human confirms the exact product and tested version.

Source classes: fda ai list, fda decision summary, vendor product page, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall

Sources

Source ledger

Sources accessed through 2026-09-03.

Alternatives

Related tools to compare

FDA-cleared K213544

TOMTEC-ARENA

TOMTEC Imaging Systems GmbH

TOMTEC-ARENA TTA2.50 analyzes ultrasound to quantify and report cardiovascular, fetal, and abdominal structures and functions, including editable AI-assisted echocardiographic...

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2022-01-06
FDA-cleared K201632

TOMTEC-ARENA

TOMTEC Imaging Systems GmbH

TOMTEC-ARENA quantifies and reports cardiovascular, fetal, and abdominal structures and functions from supported clinical images and can exchange data with IMAGE-ARENA and...

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2020-08-14